뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - remifentanil hydrochloride 1.097mg equivalent to 1 mg remifentanil;   - powder for injection - 1 mg - active: remifentanil hydrochloride 1.097mg equivalent to 1 mg remifentanil   excipient: glycine hydrochloric acid - remifentanil-aft is indicated as an analgesic agent: · for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery · for the continuation of analgesia in the immediate post-operative period during transition to longer acting analgesia · for the provision of analgesia and sedation in mechanically ventilated intensive care patients.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - remifentanil hydrochloride 2.194mg equivalent to 2 mg remifentanil;   - powder for injection - 2 mg - active: remifentanil hydrochloride 2.194mg equivalent to 2 mg remifentanil   excipient: glycine hydrochloric acid - remifentanil-aft is indicated as an analgesic agent: · for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery · for the continuation of analgesia in the immediate post-operative period during transition to longer acting analgesia · for the provision of analgesia and sedation in mechanically ventilated intensive care patients.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - remifentanil hydrochloride 5.485mg equivalent to 5 mg remifentanil;   - powder for injection - 5 mg - active: remifentanil hydrochloride 5.485mg equivalent to 5 mg remifentanil   excipient: glycine hydrochloric acid - remifentanil-aft is indicated as an analgesic agent: · for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery · for the continuation of analgesia in the immediate post-operative period during transition to longer acting analgesia · for the provision of analgesia and sedation in mechanically ventilated intensive care patients.

이스라엘 - 영어 - Ministry of Health

bioavenir ltd, israel - remifentanil as hydrochloride - powder for solution for injection - remifentanil as hydrochloride 1 mg - remifentanil - remifentanil bioavenir is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil bioavenir is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

이스라엘 - 영어 - Ministry of Health

bioavenir ltd, israel - remifentanil as hydrochloride - powder for solution for injection - remifentanil as hydrochloride 2 mg/vial - remifentanil - remifentanil bioavenir is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil bioavenir is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

이스라엘 - 영어 - Ministry of Health

bioavenir ltd, israel - remifentanil as hydrochloride - powder for solution for injection - remifentanil as hydrochloride 5 mg - remifentanil - remifentanil bioavenir is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil bioavenir is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - remifentanil hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - remifentanil hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - remifentanil hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - remifentanil hydrochloride -